In beautiful Denver, Colorado, there’s a lot to see and do! Unfortunately, symptomatic vitreomacular adhesion (VMA), can inhibit you from seeing the sights. Symptomatic VMA occurs when the gelatinous inner eye tissue, the vitreous, adheres consistently to the macula in the back of the eye, causing central vision distortion and loss, which may worsen as the disease progresses with age. About 500,000 people across the U.S. are impacted by symptomatic VMA.
The most common symptoms include:
- Decreased vision
- Blurred central vision
- Distortion of straight lines
- Dark or blank spots
Previously surgery was the only way to treat VMS. Now Jetrea is the first FDA-approved medication to treat symptomatic VMA. Jetrea is an enzyme injected into the eye that breaks down the protein that causes the vitreous to bond with the macula. This allows for a greater separation between the vitreous and the macula to be maintained, which reduces adhesion and vision distortion.
How To Use This Information
If you are experiencing any of the symptoms of VMA or have already been diagnosed, there could be hope to radically improve your vision! Ask a Denver optometrist at Vision Care Specialists about how Jetrea could help you reclaim your sight! Just give us a call at 303-991-9600 or contact us online to schedule your consultation today!
Have you considered Jetrea to address your symptomatic VMA?